Skip to content

Endoscopic Guided PCNL Versus Standard PCNL

Endoscopic Combined Intrarenal Surgery for Management of Large Renal Stones: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04825353
Enrollment
150
Registered
2021-04-01
Start date
2019-10-20
Completion date
2022-11-01
Last updated
2022-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stones, Kidney

Brief summary

currently, percutaneous nephrolithotomy (PCNL) is the standard procedure of choice for management of large renal more than 2 cm. the pivotal step in performing PCNL is creation of proper tract. this step can be done monitored under guidance of different modalities such as fluoroscopy, ultrasonography, endoscopy or combined in ECIRS, tract creation is controlled under endoscopic vision with a flexible ureteroscope .

Detailed description

Aim: compare safety and efficacy and adverse events of ECIRS in comparison of standard fluoroscopic guided PCNL. patients & methods: Patients will randomly be divided into two equal groups: Group A: Patient will undergo ECIRS. Group B: Patient will undergo standard PCNL

Interventions

PROCEDUREEndoscopic compbined guided PCNL

patient undergo stone removal by ECIRS

PROCEDUREStandard PCNL

patient undergo SPCNL

Sponsors

Benha University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with renal stones diameter of at least 2 cm. * American Society of Anesthesiology score ≤ 2.

Exclusion criteria

* patients with renal anomalies. * transplanted kidney. * uncorrected coagulopathy. * active infection.

Design outcomes

Primary

MeasureTime frameDescription
Stone Free Rate1day after operation.If their is any residual stones

Secondary

MeasureTime frameDescription
operative timeintra oprativethe length of operation
blood losspre-operative and 1 day post-oprativehemoglobin drop

Countries

Egypt

Contacts

Primary ContactWaleed El-Shaer, M.D
waleed_elshaer@hotmail.com01015767331

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026